Advances in Radioimmunotherapy: What Lymphoma Patients Should Know

On November 29, 2005, the Lymphoma Research Foundation and CancerCare brought together a distinguished panel of researchers and clinicians for a lymphoma teleconference entitled Advances in Radioimmunotherapy: What Lymphoma Patients Should Know. This program is made possible by an unrestricted educational grant to the Lymphoma Research Foundation by GlaxoSmithKline.

To listen to a recording of the teleconference via the web, click here.

To listen to a free recording of the program by telephone:
1) Call 800-625-5288 (this is the number for Genesis Company, the company that archives the telephone education workshops)
2) Enter code: 787028

Program Faculty

Oliver Press, MD, PhD
Clinical Research Division, Fred Hutchinson Cancer Research Center, Professor of Medicine, Division of Oncology, University of Washington

Stephanie A. Gregory, MD
Elodia Kehm Professor of Medicine, Director, Section of Hematology and Stem Cell Transplantation, Rush University Medical Center

Richard Dickens, MSW
Blood Cancers Program Coordinator, CancerCare, New York, NY

Jennifer Mills, LMSW, MPH, CHES
Director, Patient Education, Lymphoma Research Foundation

Topics Discussed

• Overview of lymphoma
• Diagnosis and staging
• Treatment options
• Antibody therapy
• Basics of radioimmunotherapy
• Safety considerations
• Latest research on Radioimmunotherapy for non-Hodgkin's lymphoma
• Current clinical trials
• Talking with your healthcare team
• Quality-of-life considerations

Presented in Collaboration With

• Cancer Care, Inc.
• American Society of Clinical Oncology
• Association of Clinicians for the Underserved
• Association of Oncology Social Work
• Intercultural Cancer Council
• Multinational Association of Supportive Care in Cancer